| GB0110029D0 (en) | 2001-04-24 | 2001-06-13 | Grosveld Frank | Transgenic animal |
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| ES2523661T3 (en) | 2004-07-22 | 2014-11-28 | Erasmus University Medical Center Rotterdam | Binding molecules |
| GB0601511D0 (en)* | 2006-01-25 | 2006-03-08 | Univ Erasmus Medical Ct | Binding Molecules 2 |
| BRPI0706750A2 (en) | 2006-01-25 | 2011-04-05 | Univ Erasmus Medical Ct | heavy chain antibody generation in transgenic animals |
| GB0618345D0 (en)* | 2006-09-18 | 2006-10-25 | Univ Erasmus | Binding molecules |
| EP2115004A2 (en) | 2006-12-19 | 2009-11-11 | Ablynx N.V. | Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| EP2514767A1 (en) | 2006-12-19 | 2012-10-24 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
| GB0706628D0 (en)* | 2007-04-04 | 2007-05-16 | Univ Erasmus | Germ-line manipulation 1 |
| ES2664218T3 (en) | 2007-06-01 | 2018-04-18 | Open Monoclonal Technology, Inc | Compositions and methods of inhibiting endogenous immunoglobulin genes and producing transgenic human idiotypic antibodies |
| BRPI0819656A2 (en) | 2007-11-27 | 2015-06-23 | Ablynx Nv | Amino acid sequences against heterodimeric cytokines and / or their receptors and polypeptides comprising the same |
| US8568717B2 (en) | 2008-04-03 | 2013-10-29 | Vib Vzw | Single domain antibodies capable of modulating BACE activity |
| US9908943B2 (en) | 2008-04-03 | 2018-03-06 | Vib Vzw | Single domain antibodies capable of modulating BACE activity |
| CN102056945A (en) | 2008-04-07 | 2011-05-11 | 埃博灵克斯股份有限公司 | Amino acid sequences directed against the Notch pathways and uses thereof |
| AU2009248049B2 (en) | 2008-05-16 | 2015-07-23 | Ablynx N.V. | Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same |
| WO2009143472A2 (en) | 2008-05-23 | 2009-11-26 | Aliva Biopharmaceuticals, Inc. | Method of generating single vl domain antibodies in transgenic animals |
| DK2285408T3 (en) | 2008-06-05 | 2019-02-04 | Ablynx Nv | AMINO ACID SEQUENCES AGAINST COATING PROTEINS IN A VIRUS AND POLYPEPTIDES INCLUDING THESE FOR TREATMENT OF VIRUSAL DISEASES |
| SG172176A1 (en)* | 2008-12-18 | 2011-07-28 | Univ Erasmus Medical Ct | Non-human transgenic animals expressing humanised antibodies and use therof |
| ES2729320T3 (en) | 2008-12-19 | 2019-10-31 | Ablynx Nv | Genetic immunization to produce immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4 |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| US9340605B2 (en) | 2009-10-22 | 2016-05-17 | Universiteit Twente | VHH for application in tissue repair, organ regeneration, organ replacement and tissue engineering |
| AU2010328046C1 (en) | 2009-12-10 | 2018-01-18 | Regeneron Pharmaceuticals, Inc. | Mice that make heavy chain antibodies |
| EP3309176B1 (en) | 2009-12-14 | 2025-10-01 | Ablynx N.V. | Immunoglobulin single variable domain antibodies against ox40l, constructs and their therapeutic use |
| WO2011083141A2 (en) | 2010-01-08 | 2011-07-14 | Ablynx Nv | Method for generation of immunoglobulin sequences by using lipoprotein particles |
| PT2505654T (en) | 2010-02-08 | 2016-11-18 | Regeneron Pharma | COMMON LIGHT CHAIN MOUSE |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| US9120855B2 (en) | 2010-02-10 | 2015-09-01 | Novartis Ag | Biologic compounds directed against death receptor 5 |
| WO2011117423A1 (en) | 2010-03-26 | 2011-09-29 | Ablynx N.V. | Immunoglobulin single variable domains directed against cxcr7 |
| US9101674B2 (en) | 2010-03-29 | 2015-08-11 | Vib Vzw | Targeting and in vivo imaging of tumor-associated macrophages |
| US9556273B2 (en) | 2010-03-29 | 2017-01-31 | Vib Vzw | Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| GB201014715D0 (en) | 2010-09-06 | 2010-10-20 | Vib Vzw | Nanobodies stabilizing functional conformational states of GPCRS |
| ES2612459T3 (en) | 2010-08-02 | 2017-05-17 | Regeneron Pharmaceuticals, Inc. | Mice that produce binding proteins that comprise VL domains |
| HUE036251T2 (en) | 2010-08-26 | 2018-06-28 | Agrosavfe N V | Chitinous polysaccharide antigen binding proteins |
| TWI619811B (en) | 2010-11-08 | 2018-04-01 | 諾華公司 | Chemokine receptor binding polypeptides |
| WO2012122512A1 (en) | 2011-03-10 | 2012-09-13 | Hco Antibody, Inc. | Recombinant production of mixtures of single chain antibodies |
| AU2012234284B2 (en) | 2011-03-28 | 2015-10-08 | Ablynx Nv | Bispecific anti-CXCR7 immunoglobulin single variable domains |
| UA117218C2 (en) | 2011-05-05 | 2018-07-10 | Мерк Патент Гмбх | POLYPEPTIDE AGAINST IL-17A, IL-17F AND / OR IL17-A / F |
| JP6164535B2 (en) | 2011-06-21 | 2017-07-19 | フエー・イー・ベー・フエー・ゼツト・ウエー | GPCR: Binding domain generated for G protein complex and uses derived therefrom |
| FI3865581T3 (en) | 2011-08-05 | 2024-11-02 | Regeneron Pharma | Humanized universal light chain mice |
| LT3216871T (en) | 2011-10-17 | 2022-03-25 | Regeneron Pharmaceuticals, Inc. | Restricted immunoglobulin heavy chain mice |
| BR122021007339B1 (en) | 2011-12-20 | 2022-11-29 | Regeneron Pharmaceuticals, Inc | A METHOD FOR PREPARING A NON-HUMAN ANIMAL, COMPRISING GENETIC MODIFYING AN EX VIVO NON-HUMAN ANIMAL CELL MODIFIED BY PLACING AN ADAM6 GENE, AND, EX VIVO USES OF THE CELL OR TISSUE DERIVED FROM THE NON-HUMAN ANIMAL |
| EP2617732A1 (en) | 2012-01-19 | 2013-07-24 | Vib Vzw | Tools and methods for expression of membrane proteins |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| EP2855526B1 (en) | 2012-05-24 | 2018-11-07 | VIB vzw | Anti-macrophage mannose receptor immunoglobulin single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| PT3597037T (en) | 2012-06-12 | 2021-06-01 | Regeneron Pharma | Humanized non-human animals with restricted immunoglobulin heavy chain loci |
| US9593157B2 (en) | 2013-01-30 | 2017-03-14 | Vib Vzw | Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies |
| AU2014214054B2 (en) | 2013-02-05 | 2018-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Muscarinic acetylcholine receptor binding agents and uses thereof |
| HRP20181151T1 (en) | 2013-02-20 | 2018-09-21 | Regeneron Pharmaceuticals, Inc. | Non-human animals with modified immunoglobulin heavy chain sequences |
| WO2014140376A1 (en) | 2013-03-15 | 2014-09-18 | Vib Vzw | Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases |
| WO2014141192A1 (en) | 2013-03-15 | 2014-09-18 | Erasmus University Medical Center | Generation of heavy chain-only antibodies |
| JP6687525B2 (en) | 2014-01-30 | 2020-04-22 | ブイアイビー ブイゼットダブリュＶｉｂ Ｖｚｗ | Opioid receptor binding agents and uses thereof |
| HK1231497A1 (en) | 2014-03-21 | 2017-12-22 | 瑞泽恩制药公司 | Vl antigen binding proteins exhibiting distinct binding characteristics |
| WO2015143414A2 (en) | 2014-03-21 | 2015-09-24 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
| JP2018508224A (en) | 2015-03-19 | 2018-03-29 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | Non-human animals that select light chain variable regions that bind antigen |
| WO2016187594A1 (en) | 2015-05-21 | 2016-11-24 | Harpoon Therapeutics, Inc. | Trispecific binding proteins and methods of use |
| CN105384825B (en) | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | A kind of bispecific chimeric antigen receptor and its application based on single domain antibody |
| CA3013551A1 (en) | 2016-02-05 | 2017-08-10 | Orionis Biosciences Nv | Clec9a binding agents and use thereof |
| US11248057B2 (en) | 2016-03-07 | 2022-02-15 | Vib Vzw | CD20 binding single domain antibodies |
| CA3017813C (en) | 2016-03-17 | 2021-12-07 | Oslo Universitetssykehus Hf | Fusion proteins targeting tumour associated macrophages for treating cancer |
| EP3455245A2 (en) | 2016-05-13 | 2019-03-20 | Orionis Biosciences NV | Therapeutic targeting of non-cellular structures |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| US10100106B2 (en) | 2016-05-20 | 2018-10-16 | Harpoon Therapeutics, Inc. | Single domain serum albumin binding protein |
| WO2017201493A1 (en) | 2016-05-20 | 2017-11-23 | Harpoon Therapeutics, Inc. | Single chain variable fragment cd3 binding proteins |
| WO2018014260A1 (en) | 2016-07-20 | 2018-01-25 | Nanjing Legend Biotech Co., Ltd. | Multispecific antigen binding proteins and methods of use thereof |
| WO2018068201A1 (en) | 2016-10-11 | 2018-04-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against ctla-4 |
| BR112019010602A2 (en) | 2016-11-23 | 2019-12-17 | Harpoon Therapeutics Inc | trispecific psma proteins and methods of use |
| KR20210087108A (en) | 2016-11-23 | 2021-07-09 | 하푼 테라퓨틱스, 인크. | Prostate specific membrane antigen binding protein |
| JP2020505037A (en) | 2017-01-19 | 2020-02-20 | オープン モノクローナル テクノロジー，インコーポレイテッド | Human antibodies from transgenic rodents having multiple heavy chain immunoglobulin loci |
| CN110546160A (en) | 2017-02-06 | 2019-12-06 | 奥里尼斯生物科学公司 | Targeted chimeric proteins and their uses |
| US11535668B2 (en) | 2017-02-28 | 2022-12-27 | Harpoon Therapeutics, Inc. | Inducible monovalent antigen binding protein |
| CN115028727A (en) | 2017-05-12 | 2022-09-09 | 哈普恩治疗公司 | MSLN-targeting trispecific proteins and methods of use |
| US10543271B2 (en) | 2017-05-12 | 2020-01-28 | Harpoon Therapeutics, Inc. | Mesothelin binding proteins |
| WO2018222587A1 (en) | 2017-05-30 | 2018-12-06 | The Regents Of The University Of California | NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif) |
| WO2019000223A1 (en) | 2017-06-27 | 2019-01-03 | Nanjing Legend Biotech Co., Ltd. | Chimeric antibody immune effctor cell engagers and methods of use thereof |
| AU2018347582B2 (en) | 2017-10-13 | 2025-08-28 | Harpoon Therapeutics, Inc. | Trispecific proteins and methods of use |
| IL315737A (en) | 2017-10-13 | 2024-11-01 | Harpoon Therapeutics Inc | B cell maturation antigen binding proteins |
| TW201930350A (en) | 2017-12-28 | 2019-08-01 | 大陸商南京傳奇生物科技有限公司 | Antibodies and variants thereof against PD-L1 |
| JP7369127B2 (en) | 2017-12-28 | 2023-10-25 | ナンジン レジェンド バイオテック カンパニー，リミテッド | Single domain antibodies against TIGIT and variants thereof |
| EP3740507A4 (en) | 2018-01-15 | 2022-08-24 | Nanjing Legend Biotech Co., Ltd. | SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST PD-1 |
| WO2019148089A1 (en) | 2018-01-26 | 2019-08-01 | Orionis Biosciences Inc. | Xcr1 binding agents and uses thereof |
| CA3090406A1 (en) | 2018-02-05 | 2019-08-08 | Orionis Biosciences, Inc. | Fibroblast binding agents and use thereof |
| JP7346790B2 (en) | 2018-03-30 | 2023-09-20 | ナンジン レジェンド バイオテック カンパニー，リミテッド | Single domain antibodies against LAG-3 and their uses |
| CA3100327A1 (en) | 2018-05-14 | 2019-11-21 | Harpoon Therapeutics, Inc. | Binding moiety for conditional activation of immunoglobulin molecules |
| WO2019227490A1 (en) | 2018-06-01 | 2019-12-05 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and methods for imaging |
| US11987629B2 (en) | 2018-06-01 | 2024-05-21 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and uses thereof for treating disease or condition |
| GB2576914A (en) | 2018-09-06 | 2020-03-11 | Kymab Ltd | Antigen-binding molecules comprising unpaired variable domains produced in mammals |
| CN112673022B (en) | 2018-09-10 | 2024-07-09 | 南京传奇生物科技有限公司 | Single domain antibodies to CD33 and constructs thereof |
| US12195544B2 (en) | 2018-09-21 | 2025-01-14 | Harpoon Therapeutics, Inc. | EGFR binding proteins and methods of use |
| CA3114038A1 (en) | 2018-09-25 | 2020-04-02 | Harpoon Therapeutics, Inc. | Dll3 binding proteins and methods of use |
| JP7538130B2 (en) | 2019-01-23 | 2024-08-21 | タユー ファシャ バイオテック メディカル グループ カンパニー， リミテッド | Anti-PD-L1 diabodies and uses thereof |
| BR112021022874A2 (en) | 2019-05-14 | 2022-03-22 | Harpoon Therapeutics Inc | epcam binding proteins and methods of use |
| CN110818795B (en) | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | anti-TIGIT antibodies and methods of use |
| MX2022010175A (en) | 2020-02-21 | 2022-09-12 | Harpoon Therapeutics Inc | Flt3 binding proteins and methods of use. |
| EP4110826A4 (en) | 2020-02-28 | 2024-08-14 | Shanghai Henlius Biotech, Inc. | Anti-cd137 constructs, multispecific antibody and uses thereof |
| CN115066440A (en) | 2020-02-28 | 2022-09-16 | 上海复宏汉霖生物技术股份有限公司 | anti-CD 137 constructs and uses thereof |
| CN116529260A (en) | 2020-06-02 | 2023-08-01 | 当康生物技术有限责任公司 | anti-CD 93 constructs and uses thereof |
| EP4157462A1 (en) | 2020-06-02 | 2023-04-05 | Dynamicure Biotechnology LLC | Anti-cd93 constructs and uses thereof |
| JP2023530919A (en) | 2020-06-17 | 2023-07-20 | ヤンセン バイオテツク，インコーポレーテツド | Materials and methods for production of pluripotent stem cells |
| US20230322935A1 (en) | 2020-07-29 | 2023-10-12 | Dynamicure Biotechnology Llc | Anti-cd93 constructs and uses thereof |
| IL301763A (en) | 2020-09-28 | 2023-05-01 | Angitia Biomedicines Ltd | Antisclerostin structures and their uses |
| WO2022156908A1 (en) | 2021-01-25 | 2022-07-28 | Vrije Universiteit Brussel | Method for preparing a lyophilized composition |
| WO2022157373A1 (en) | 2021-01-25 | 2022-07-28 | Vrije Universiteit Brussel | Compositions and kits for in vivo imaging of cardiac sarcoidosis |
| WO2022156907A1 (en) | 2021-01-25 | 2022-07-28 | Vrije Universiteit Brussel | Method and kit for labeling a biomolecule with one or more detectable labels, including a radiolabel |
| CA3209052A1 (en) | 2021-02-19 | 2022-08-25 | Rafael Cristian CASELLAS | Single domain antibodies that neutralize sars-cov-2 |
| EP4296284A4 (en) | 2021-02-19 | 2025-03-05 | SHAPERON Inc. | SINGLE-DOMAIN BISPECIFIC ANTIBODY AGAINST PD-L1 AND CD47 AND ITS USE |
| BR112023016713A2 (en) | 2021-02-19 | 2023-10-31 | Seoul Nat Univ R&Db Foundation | Antibody or an antigen-binding fragment thereof, nucleic acid molecule, methods for producing an antibody or an antigen-binding fragment thereof and for detecting cluster of differentiation 47 or determining an amount of cluster of differentiation 47 in a sample, and, use of the antibody or an antigen-binding fragment thereof |
| BR112023016706A2 (en) | 2021-02-19 | 2023-10-31 | Seoul Nat Univ R&Db Foundation | Antibody or an antigen-binding fragment thereof, nucleic acid molecule, methods for producing an antibody or an antigen-binding fragment thereof and for detecting cluster of differentiation 47 or determining an amount of cluster of differentiation 47 in a sample, and, use of the antibody or an antigen-binding fragment thereof |
| EP4301472A1 (en) | 2021-03-05 | 2024-01-10 | Dynamicure Biotechnology LLC | Anti-vista constructs and uses thereof |
| TW202300648A (en) | 2021-03-25 | 2023-01-01 | 美商當康生物科技有限公司 | Anti-igfbp7 constructs and uses thereof |
| WO2022266660A1 (en) | 2021-06-17 | 2022-12-22 | Amberstone Biosciences, Inc. | Anti-cd3 constructs and uses thereof |
| WO2022269473A1 (en) | 2021-06-23 | 2022-12-29 | Janssen Biotech, Inc. | Materials and methods for hinge regions in functional exogenous receptors |
| EP4412663A1 (en) | 2021-10-05 | 2024-08-14 | Vrije Universiteit Brussel | Fluorescently labeled immunoglobulin single variable domains |
| EP4448579A1 (en) | 2021-12-17 | 2024-10-23 | Shanghai Henlius Biotech, Inc. | Anti-ox40 antibodies and methods of use |
| CA3240585A1 (en) | 2021-12-17 | 2023-06-22 | Wenfeng Xu | Anti-ox40 antibodies, multispecific antibodies and methods of use |
| WO2023179740A1 (en) | 2022-03-25 | 2023-09-28 | Shanghai Henlius Biotech , Inc. | Anti-msln antibodies and methods of use |
| US20250188492A1 (en) | 2022-07-22 | 2025-06-12 | Janssen Biotech, Inc. | Enhanced Transfer of Genetic Instructions to Effector Immune Cells |
| CN120077071A (en) | 2022-09-07 | 2025-05-30 | 当康生物技术有限责任公司 | Anti-VISTA constructs and uses thereof |
| EP4349374A1 (en) | 2022-10-05 | 2024-04-10 | Vrije Universiteit Brussel | Anti-urokinase plasminogen activator receptor immunoglobulin single variable domains |
| WO2024083843A1 (en) | 2022-10-18 | 2024-04-25 | Confo Therapeutics N.V. | Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders |
| WO2025034806A1 (en) | 2023-08-08 | 2025-02-13 | Wisconsin Alumni Research Foundation | Single-domain antibodies and variants thereof against fibroblast activation protein |
| EP4512243A1 (en) | 2023-08-21 | 2025-02-26 | Kymab Limited | Binding molecules |
| WO2025045251A2 (en) | 2023-09-03 | 2025-03-06 | Kira Pharmaceuticals (Us) Llc | Multispecific constructs comprising anti-factor d moiety |
| WO2025088085A1 (en) | 2023-10-26 | 2025-05-01 | Abscint Nv | Image guided biopsy of her2 positive lesions |
| WO2025178959A1 (en) | 2024-02-20 | 2025-08-28 | University Of Georgia Research Foundation, Inc. | Single-domain antibodies and variants thereof against tab1 |